Health In Tech, Inc. Selling and Marketing Expense
Health In Tech, Inc. (HIT) reported Selling and Marketing Expense of $2.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-13
- Health In Tech, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $2.22M, a 80.63% increase year-over-year.
- Health In Tech, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $2.29M, a 110.19% increase year-over-year.
- Health In Tech, Inc. selling and marketing expense for the quarter ending 2025-12-31 was $906.21K, a 43.37% increase year-over-year.
- Health In Tech, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $962.57K, a 89.31% increase year-over-year.
- Health In Tech, Inc. selling and marketing expense for fiscal 2025 was $4.19M, a 32.53% increase from fiscal 2024.
- Health In Tech, Inc. selling and marketing expense for fiscal 2024 was $3.16M, a 6.57% decline from fiscal 2023.
- Health In Tech, Inc. selling and marketing expense for fiscal 2023 was $3.38M.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.22M 10-Q · filed 2026-08-13 | $4.51M 10-Q · filed 2026-08-13 | $5.41M derived: sum of 3 quarters · filed 2026-08-13 | $6.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $2.29M 10-Q · filed 2026-05-14 | $3.20M derived: sum of 2 quarters · filed 2026-05-14 | $4.16M derived: sum of 3 quarters · filed 2026-05-14 | $5.39M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $906.21K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.87M derived: sum of 2 quarters · filed 2026-03-25 | $3.10M derived: sum of 3 quarters · filed 2026-08-13 | $4.19M 10-K · filed 2026-03-25 |
| 2025-09-30 | $962.57K 10-Q · filed 2025-11-12 | $2.19M derived: sum of 2 quarters · filed 2026-08-13 | $3.28M 10-Q · filed 2025-11-12 | $3.91M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.23M 10-Q · filed 2026-08-13 | $2.32M 10-Q · filed 2026-08-13 | $2.95M derived: sum of 3 quarters · filed 2026-08-13 | $3.46M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.09M 10-Q · filed 2026-05-14 | $1.72M derived: sum of 2 quarters · filed 2026-05-14 | $2.23M derived: sum of 3 quarters · filed 2026-05-14 | $3.21M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $632.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.14M derived: sum of 2 quarters · filed 2026-03-25 | $2.12M derived: sum of 3 quarters · filed 2026-03-25 | $3.16M 10-K · filed 2026-03-25 |
| 2024-09-30 | $508.47K 10-Q · filed 2025-11-12 | $1.48M derived: sum of 2 quarters · filed 2025-11-12 | $2.53M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $974.52K 10-Q · filed 2025-08-08 | $2.02M 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $1.04M 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | $3.38M 10-K · filed 2025-03-17 |